article thumbnail

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

article thumbnail

Tobacco Use Screening In Community-Based Primary Care Clinics By Visit Modality During The Covid-19 Pandemic [Smoking cessation]

Annals of Family Medicine

Context: Primary care delivery was significantly impacted by COVID-19, with rapid deployment of telehealth after the United States’ national public health emergency (PHE) declaration in March 2020. In the years following the PHE, rates of screening for tobacco use decreased, particularly during telehealth visits.

article thumbnail

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

This draft guidance builds on recommendations that FDA initially developed early in 2020, in response to the COVID-19 challenges (see our blog post on these recommendations here ). Study visits can be conducted using telehealth visits if in-person interaction is not necessary. Trial personnel can also be sent to participant’s homes.

Clinic 59